Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-10-03T04:35:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.
    Difference
    4%
    Check dated 2024-09-25T22:02:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    4%
    Check dated 2024-09-18T16:22:42.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    New content was added on September 5, 2024, following the previous deletions on July 29, 2024.
    Difference
    0.7%
    Check dated 2024-09-11T06:59:14.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.3%
    Check dated 2024-09-04T03:36:09.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T21:49:49.000Z thumbnail image

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.